In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Deals That Generate Lasting Value: A Roundtable Discussion

Executive Summary

At Elsevier Business Intelligence's recent Therapeutic Area Partnerships conference, a  roundtable of senior pharmaceutical executives and entrepreneurs weighed in on industry’s current funding challenges, how dealmaking defines a biotech’s ambitions and strategy, and pharma’s appetite for early-stage innovation.

Advertisement

Related Content

Aileron Overcoming Spirited Debate About Stapled Peptides
Pursuit Of R&D Efficiency Continues As Regulatory Options Expand In 2013 – Tufts CSDD
With Dueling Papers Comes A Spirited Debate About Stapled Peptides
Meet Merck’s Dealmaker: A Conversation With Roger Pomerantz
Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties
Roche Partners With Peptide Specialist Aileron For Five Targets

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel